Kerem Teke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kerem Teke has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Murat Akgül
Umraniye Training & Research Hospital, Department of Urology, Health Sciences University, İstanbul, Turkey
11 shared publications - Cem Basatac
Department of Urology, Demiroglu Bilim University, Istanbul, Turkey
9 shared publications - Oktay Özman
Clinic of Urology, Memorial Bahçelievler Hospital, Istanbul, Turkey
9 shared publications - Onder Cinar
Department of Urology, MEDICANA International, Samsun, Turkey
9 shared publications - Bulent Onal
Department of Urology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
8 shared publications - Cenk Murat Yazıcı
Department of Urology, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
8 shared publications
Latest Publications
- Open Access
- 17 April 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (2) , 223-231
Boron neutron capture therapy (BNCT) for experimental bladder cancer: systemic or intravesical approach
Background: To investigate the antitumoral and pro-inflammatory effect of Boron Neutron Capture Therapy (BNCT) following systemic or intravesical borophenilalanine administration, and to compare it with conventional radiotherapy (cRT) in an experimental bladder cancer (BC) model. Methods: Sixty-four Wistar rats were used, of which half were exposed to carcinogen to induce BC. Radiation therapy (RT) was performed both in the MARK TRIGA-II reactor for BNCT and in the Radiation Oncology divison for cRT. After necropsy, bladder and perivesical tissues were collected. Tumour staging, tumour burden, proliferative, and apoptotic indexes were evaluated for bladder samples. Bladder and perivesical tissues (colon, uterus, and anterior abdominal wall) were also assessed for inflammatory changes in H&E-stained sections, and also bladder TNF-α expressions was examined by immunohistochemistry and Western blot. Results: The animals with cancer had a 15–30% decrease in tumour burden after RT. The incidence of persistent papillary urothelial carcinoma was 100% in the Cancer-cRT group and 87.5% in the Cancer-BNCT-Sys group, whereas a lower incidence was observed in the Cancer-BNCT-IV group (71.4%). A lower proliferative and a higher apoptotic indexes were observed in Cancer-BNCT-IV group compared to Cancer-cRT. Immunohistochemistry and Western blot for TNF-α expression showed that pro-inflammatory response in bladder was lower in BNCT-IV group among cancer treated groups. Moreover, there were lower proinflammatory adverse findings in perivesical tissues, including colon and uterus, in animals receiving BNCT-IV. Conclusion: Similar to cRT, systemic or intravesical BNCT resulted in a partial decrease in tumour burden, but fewer adverse findings by intravesical borophenilalanine.
- 17 April 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (2) , 223-231
Open AccessBoron neutron capture therapy (BNCT) for experimental bladder cancer: systemic or intravesical approach
Background: To investigate the antitumoral and pro-inflammatory effect of Boron Neutron Capture Therapy (BNCT) following systemic or intravesical borophenilalanine administration, and to compare it with conventional radiotherapy (cRT) in an experimental bladder cancer (BC) model. Methods: Sixty-four Wistar rats were used, of which half were exposed to carcinogen to induce BC. Radiation therapy (RT) was performed both in the MARK TRIGA-II reactor for BNCT and in the Radiation Oncology divison for cRT. After necropsy, bladder and perivesical tissues were collected. Tumour staging, tumour burden, proliferative, and apoptotic indexes were evaluated for bladder samples. Bladder and perivesical tissues (colon, uterus, and anterior abdominal wall) were also assessed for inflammatory changes in H&E-stained sections, and also bladder TNF-α expressions was examined by immunohistochemistry and Western blot. Results: The animals with cancer had a 15–30% decrease in tumour burden after RT. The incidence of persistent papillary urothelial carcinoma was 100% in the Cancer-cRT group and 87.5% in the Cancer-BNCT-Sys group, whereas a lower incidence was observed in the Cancer-BNCT-IV group (71.4%). A lower proliferative and a higher apoptotic indexes were observed in Cancer-BNCT-IV group compared to Cancer-cRT. Immunohistochemistry and Western blot for TNF-α expression showed that pro-inflammatory response in bladder was lower in BNCT-IV group among cancer treated groups. Moreover, there were lower proinflammatory adverse findings in perivesical tissues, including colon and uterus, in animals receiving BNCT-IV. Conclusion: Similar to cRT, systemic or intravesical BNCT resulted in a partial decrease in tumour burden, but fewer adverse findings by intravesical borophenilalanine.
- Open Access
- 1 January 2026
- Published by SAGE Publications in Bladder Cancer
- Vol. 12 (1)
Analysis of sarcopenia indicators on survival prediction undergoing radical cystectomy
Background: Sarcopenia is increasingly recognized as an imaging-based prognostic factor in various cancers, but its gender-specific radiological indicators in bladder cancer patients undergoing radical cystectomy are not well defined. Objective: The aim of this study was to identify the radiological sarcopenia parameters that can be used to predict overall survival(OS) in patients who underwent radical cystectomy(RC). Methods: The data of a total of 183 patients who underwent RC for urothelial bladder cancer and had an abdominal computed tomography(CT) scan within three months prior to surgery, were retrospectively analyzed. Skeletal muscle areas at the L3 vertebral level and average Hounsfield unit(HU) measurements were extracted from the CT images.Based on these measurements, five sarcopenia-related parameters [skeletal muscle index (SMI) type 1, SMI type 2, psoas muscle index(PMI) type 1, PMI type 2, and skeletal muscle density(SMD)] were calculated and investigated their prognostic effect on OS using uni- and multi-variable Cox regression analysis. Results: The median follow-up period was 22 months(IQR: 10–50).In univariate Cox regression analysis, significant factors affecting overall survival in men included age, pT stage, pN stage, SMI type 1, SMI type 2, and PMI type 2(p < 0.05).In women, significant factors included pT stage, pN stage, and only SMD(p < 0.05).Among radiologic sarcopenia markers, multivariate Cox regression models indicated that significance of the SMI type 1, the SMI type 2 and the PMI type 2 remained as prognostic factors for overall survival in men(p < 0.05). In women, only SMD remained significant(p = 0.018). Conclusions: Our analysis highlighted that gender-specific radiological sarcopenic parameters impact on OS among patients undergoing RC.SMI type 1, SMI type 2, and PMI type 2 for male and only SMD for female were prognosticators in patients undergoing RC.
- 1 January 2026
- Published by SAGE Publications in Bladder Cancer
- Vol. 12 (1)
Open AccessAnalysis of sarcopenia indicators on survival prediction undergoing radical cystectomy
Background: Sarcopenia is increasingly recognized as an imaging-based prognostic factor in various cancers, but its gender-specific radiological indicators in bladder cancer patients undergoing radical cystectomy are not well defined. Objective: The aim of this study was to identify the radiological sarcopenia parameters that can be used to predict overall survival(OS) in patients who underwent radical cystectomy(RC). Methods: The data of a total of 183 patients who underwent RC for urothelial bladder cancer and had an abdominal computed tomography(CT) scan within three months prior to surgery, were retrospectively analyzed. Skeletal muscle areas at the L3 vertebral level and average Hounsfield unit(HU) measurements were extracted from the CT images.Based on these measurements, five sarcopenia-related parameters [skeletal muscle index (SMI) type 1, SMI type 2, psoas muscle index(PMI) type 1, PMI type 2, and skeletal muscle density(SMD)] were calculated and investigated their prognostic effect on OS using uni- and multi-variable Cox regression analysis. Results: The median follow-up period was 22 months(IQR: 10–50).In univariate Cox regression analysis, significant factors affecting overall survival in men included age, pT stage, pN stage, SMI type 1, SMI type 2, and PMI type 2(p < 0.05).In women, significant factors included pT stage, pN stage, and only SMD(p < 0.05).Among radiologic sarcopenia markers, multivariate Cox regression models indicated that significance of the SMI type 1, the SMI type 2 and the PMI type 2 remained as prognostic factors for overall survival in men(p < 0.05). In women, only SMD remained significant(p = 0.018). Conclusions: Our analysis highlighted that gender-specific radiological sarcopenic parameters impact on OS among patients undergoing RC.SMI type 1, SMI type 2, and PMI type 2 for male and only SMD for female were prognosticators in patients undergoing RC.
- 28 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Outcomes of retrograde intrarenal surgery in patients on anticoagulant or antiplatelet therapy: a multicenter matched case–control study by the RIRSearch Study Group
- 28 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Outcomes of retrograde intrarenal surgery in patients on anticoagulant or antiplatelet therapy: a multicenter matched case–control study by the RIRSearch Study Group
- 21 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Evaluation of inflammatory markers in survival analysis of patients undergoing radical cystectomy using machine learning
Background We aimed to create a Machine learning (ML) model using patient demographic, clinical and pathological data for prediction of overall survival in patients treated with radical cystectomy (RC). Secondly, we evaluated whether inflammatory markers contributed to this model. Methods We conducted a retrospective analysis of the institutional cystectomy database and identified consecutive RC patients. Dataset-1 (DS-1) was analyzed in ML models using 30 original features (including the target feature) encompassing preoperative, intraoperative, and postoperative data of the patients. All derived inflammatory markers were cumulatively added to DS-1 to create DS-2, and to test the specific contribution of inflammatory markers, they were systematically integrated in an ordinary order based on their predictive ability (DS-3). Markers without predictive contribution were excluded from the DS-3 model. In addition, the Shapley Additive Explanations (SHAP) method was used to examine the importance of each clinical feature and inflammatory marker. Results The median age of the 241 patients was 65 years. The mortality rate was 60.2% (145/241). Two- and five-year overall survival (OS) rates were 54.7% and 37.2%, respectively. According to DS-1, F1 scores were between 0.72 and 0.78. Random Forests and XGBoost models achieved the highest score of 0.78. DS-2 including all inflammatory markers; however, no significant improvement in F1 scores was observed (0.73–0.78). In DS-3, firstly adding the systemic inflammatory response index (SIRI) to the original features and then neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR), achieved the highest F1 score (0.80) in the Random Forest model. SHAP analyses showed that Tumor (T) stage, preoperative albumin and presence of lympho-vascular invasion (LVI) contributed most to model predictivity. Conclusions ML models derived using demographic/clinical features resulted in a maximum F1 score of 0.78. However, adding the most predictive inflammatory markers in the sequence SIRI, NLR and PLR to demographic data achieved the highest F1 score of 0.80. Furthermore, T stage and preoperative albumin were the strongest predictive factors in the ML models.
- 21 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Evaluation of inflammatory markers in survival analysis of patients undergoing radical cystectomy using machine learning
Background We aimed to create a Machine learning (ML) model using patient demographic, clinical and pathological data for prediction of overall survival in patients treated with radical cystectomy (RC). Secondly, we evaluated whether inflammatory markers contributed to this model. Methods We conducted a retrospective analysis of the institutional cystectomy database and identified consecutive RC patients. Dataset-1 (DS-1) was analyzed in ML models using 30 original features (including the target feature) encompassing preoperative, intraoperative, and postoperative data of the patients. All derived inflammatory markers were cumulatively added to DS-1 to create DS-2, and to test the specific contribution of inflammatory markers, they were systematically integrated in an ordinary order based on their predictive ability (DS-3). Markers without predictive contribution were excluded from the DS-3 model. In addition, the Shapley Additive Explanations (SHAP) method was used to examine the importance of each clinical feature and inflammatory marker. Results The median age of the 241 patients was 65 years. The mortality rate was 60.2% (145/241). Two- and five-year overall survival (OS) rates were 54.7% and 37.2%, respectively. According to DS-1, F1 scores were between 0.72 and 0.78. Random Forests and XGBoost models achieved the highest score of 0.78. DS-2 including all inflammatory markers; however, no significant improvement in F1 scores was observed (0.73–0.78). In DS-3, firstly adding the systemic inflammatory response index (SIRI) to the original features and then neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR), achieved the highest F1 score (0.80) in the Random Forest model. SHAP analyses showed that Tumor (T) stage, preoperative albumin and presence of lympho-vascular invasion (LVI) contributed most to model predictivity. Conclusions ML models derived using demographic/clinical features resulted in a maximum F1 score of 0.78. However, adding the most predictive inflammatory markers in the sequence SIRI, NLR and PLR to demographic data achieved the highest F1 score of 0.80. Furthermore, T stage and preoperative albumin were the strongest predictive factors in the ML models.
- 1 October 2025
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 35 (10) , 792-797
The Impact of Preoperative JJ Stent Diameter on Retrograde Intrarenal Surgery: A RIRSearch Group Study
Introduction: A JJ stent placed before retrograde intrarenal surgery (RIRS) may passively dilate the ureter and facilitate ureteral access sheath (UAS) implantation. No studies have examined the significance of preoperative JJ stent diameter, even though numerous studies have shown that UAS insertion is simpler in patients with them. Our study examines the relationship between preoperative ureteral stent caliber and UAS placement and RIRS results. Materials and Methods: A total of 655 patients with known preoperative double-J stent size before RIRS were analyzed. The patients were categorized into two groups based on their preoperative stent diameter (Group 1: 4.8 Fr and Group 2: 6 Fr). Demographic and clinical data of the patients, stone characteristics, surgical data, perioperative and postoperative complications, duration of hospitalization, and stone-free rates (SFRs) were analyzed for comparison. Results: The groups contained 323 and 332 patients. The demographic data of the two groups were similar. There was no statistically significant difference between SFR, UAS insertion rate, hospitalization time, and complications. The success rate of placing a UAS with a higher caliber was statistically significantly higher in those with a 6 Fr JJ stent than in those with a 4.8 Fr stent ( P = .001 ). The operation time was also shorter in the group with a thicker stent ( P = .003 ). Conclusions: Our data suggest that while the preoperative JJ stent diameter does not significantly affect overall UAS insertion success, complication rates, or postoperative stone-free status, using a 6 Fr stent facilitates the placement of larger UAS calibers and may decrease operation time. Consequently, although both stent diameters are efficacious, selecting a 6 Fr stent may provide procedural benefits without jeopardizing safety or results.
- 1 October 2025
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 35 (10) , 792-797
The Impact of Preoperative JJ Stent Diameter on Retrograde Intrarenal Surgery: A RIRSearch Group Study
Introduction: A JJ stent placed before retrograde intrarenal surgery (RIRS) may passively dilate the ureter and facilitate ureteral access sheath (UAS) implantation. No studies have examined the significance of preoperative JJ stent diameter, even though numerous studies have shown that UAS insertion is simpler in patients with them. Our study examines the relationship between preoperative ureteral stent caliber and UAS placement and RIRS results. Materials and Methods: A total of 655 patients with known preoperative double-J stent size before RIRS were analyzed. The patients were categorized into two groups based on their preoperative stent diameter (Group 1: 4.8 Fr and Group 2: 6 Fr). Demographic and clinical data of the patients, stone characteristics, surgical data, perioperative and postoperative complications, duration of hospitalization, and stone-free rates (SFRs) were analyzed for comparison. Results: The groups contained 323 and 332 patients. The demographic data of the two groups were similar. There was no statistically significant difference between SFR, UAS insertion rate, hospitalization time, and complications. The success rate of placing a UAS with a higher caliber was statistically significantly higher in those with a 6 Fr JJ stent than in those with a 4.8 Fr stent ( P = .001 ). The operation time was also shorter in the group with a thicker stent ( P = .003 ). Conclusions: Our data suggest that while the preoperative JJ stent diameter does not significantly affect overall UAS insertion success, complication rates, or postoperative stone-free status, using a 6 Fr stent facilitates the placement of larger UAS calibers and may decrease operation time. Consequently, although both stent diameters are efficacious, selecting a 6 Fr stent may provide procedural benefits without jeopardizing safety or results.
- Open Access
- 24 May 2025
- Published by Springer Nature in BMC Urology
- Vol. 25 (1) , 1-9
The role of tumor-infiltrating lymphocytes and depth of invasion in T1 bladder cancer: a retrospective analysis
Tumor-infiltrating lymphocytes (TILs) are integral components of the tumor microenvironment and have been extensively studied across various cancers. In bladder cancer, the prognostic significance of TILs remains uncertain. This study aimed to analyze the impact of muscularis mucosa invasion and TILs ratios on clinical outcomes, tumor aggressiveness, and prognosis in pT1 urothelial carcinoma of the bladder. This retrospective study included 154 patients with pT1 bladder urothelial carcinoma, categorized into pT1a and pT1b groups based on the extent of muscularis mucosa invasion. TILs ratios were stratified into three groups: 5%. Clinical and pathological characteristics, including tumor diameter, necrosis, tumor thickness, recurrence, and progression rates, were compared. Depth of invasion and tumor features were assessed using standard histopathological methods. Recurrence and progression-free survival (PFS) were evaluated during a median follow-up of 20 months. By definition, pT1b tumors demonstrated significantly deeper invasion into the muscularis mucosa (p < 0.0001) compared to pT1a tumors. They were also associated with larger tumor diameter (p = 0.023), greater tumor thickness (p < 0.0001), and increased necrosis (p = 0.0012). Radical cystectomy was performed more frequently in pT1b patients (19.2%) than in pT1a patients (7.9%), although recurrence and PFS rates did not differ significantly between the groups. Higher TILs ratios were linked to increased tumor thickness (p = 0.0299) and more extensive invasion into TURBT chips (p = 0.0025), but no significant differences in recurrence or PFS rates were observed across TILs groups. Muscularis mucosa invasion is a defining feature of pT1b bladder cancer and serves as a key indicator of tumor aggressiveness. While TILs were associated with aggressive tumor characteristics, their prognostic role remains inconclusive. These findings highlight the need for aggressive management strategies for pT1b disease and underscore the importance of further research into the complex interplay between TILs and tumor progression in bladder cancer.
- 24 May 2025
- Published by Springer Nature in BMC Urology
- Vol. 25 (1) , 1-9
Open AccessThe role of tumor-infiltrating lymphocytes and depth of invasion in T1 bladder cancer: a retrospective analysis
Tumor-infiltrating lymphocytes (TILs) are integral components of the tumor microenvironment and have been extensively studied across various cancers. In bladder cancer, the prognostic significance of TILs remains uncertain. This study aimed to analyze the impact of muscularis mucosa invasion and TILs ratios on clinical outcomes, tumor aggressiveness, and prognosis in pT1 urothelial carcinoma of the bladder. This retrospective study included 154 patients with pT1 bladder urothelial carcinoma, categorized into pT1a and pT1b groups based on the extent of muscularis mucosa invasion. TILs ratios were stratified into three groups: 5%. Clinical and pathological characteristics, including tumor diameter, necrosis, tumor thickness, recurrence, and progression rates, were compared. Depth of invasion and tumor features were assessed using standard histopathological methods. Recurrence and progression-free survival (PFS) were evaluated during a median follow-up of 20 months. By definition, pT1b tumors demonstrated significantly deeper invasion into the muscularis mucosa (p < 0.0001) compared to pT1a tumors. They were also associated with larger tumor diameter (p = 0.023), greater tumor thickness (p < 0.0001), and increased necrosis (p = 0.0012). Radical cystectomy was performed more frequently in pT1b patients (19.2%) than in pT1a patients (7.9%), although recurrence and PFS rates did not differ significantly between the groups. Higher TILs ratios were linked to increased tumor thickness (p = 0.0299) and more extensive invasion into TURBT chips (p = 0.0025), but no significant differences in recurrence or PFS rates were observed across TILs groups. Muscularis mucosa invasion is a defining feature of pT1b bladder cancer and serves as a key indicator of tumor aggressiveness. While TILs were associated with aggressive tumor characteristics, their prognostic role remains inconclusive. These findings highlight the need for aggressive management strategies for pT1b disease and underscore the importance of further research into the complex interplay between TILs and tumor progression in bladder cancer.
- 13 May 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (12) , 3985-3992
The comparison of efficacy and safety of reusable and disposable-flexible ureteroscopes: case-control matching results of multicentric RIRSearch study group
Purpose Today, disposable flexible ureteroscopes are increasingly used in retrograde intrarenal surgery (RIRS) as an alternative to reusable flexible ureteroscopes. The comparison of the safety and effectiveness of these two devices is still a matter of debate. This study evaluates the efficacy and safety of disposable-flexible ureteroscopes vs reusable flexible ureteroscopes in RIRS. Materials and methods The study included 1165 RIRS cases, and the patients were divided into two groups. Group 1 consisted of cases with reusable RIRS, 838 in total, while Group 2 consisted of disposable RIRS cases, 327 in total. Due to significant differences, case–control matching was performed, and subsequently, there were 229 patients in both groups. The demographic and clinical data of patients, stone characteristics, surgical data, perioperative and postoperative complications, postoperative urinary tract infection rate, duration of hospitalization, and stone-free rates (SFR) were analyzed and compared. Results No demographic differences were observed between the two groups after case–control matching. While operative time, SFR, and postoperative infection rates were similar between the groups (p > 0.05), fluoroscopy (p = 0.001) and hospitalization (p = 0.029) times were statistically significantly lower in the disposable ureteroscopy group. Perioperative and postoperative complications were also lower in this group (p = 0.018 and p = 0.001 respectively). Conclusion Our research indicates that single-use ureteroscopes are a strong alternative to reusable ureteroscopes, demonstrating similar efficacy and reduced complication rates in the treatment of upper urinary tract stones.
- 13 May 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (12) , 3985-3992
The comparison of efficacy and safety of reusable and disposable-flexible ureteroscopes: case-control matching results of multicentric RIRSearch study group
Purpose Today, disposable flexible ureteroscopes are increasingly used in retrograde intrarenal surgery (RIRS) as an alternative to reusable flexible ureteroscopes. The comparison of the safety and effectiveness of these two devices is still a matter of debate. This study evaluates the efficacy and safety of disposable-flexible ureteroscopes vs reusable flexible ureteroscopes in RIRS. Materials and methods The study included 1165 RIRS cases, and the patients were divided into two groups. Group 1 consisted of cases with reusable RIRS, 838 in total, while Group 2 consisted of disposable RIRS cases, 327 in total. Due to significant differences, case–control matching was performed, and subsequently, there were 229 patients in both groups. The demographic and clinical data of patients, stone characteristics, surgical data, perioperative and postoperative complications, postoperative urinary tract infection rate, duration of hospitalization, and stone-free rates (SFR) were analyzed and compared. Results No demographic differences were observed between the two groups after case–control matching. While operative time, SFR, and postoperative infection rates were similar between the groups (p > 0.05), fluoroscopy (p = 0.001) and hospitalization (p = 0.029) times were statistically significantly lower in the disposable ureteroscopy group. Perioperative and postoperative complications were also lower in this group (p = 0.018 and p = 0.001 respectively). Conclusion Our research indicates that single-use ureteroscopes are a strong alternative to reusable ureteroscopes, demonstrating similar efficacy and reduced complication rates in the treatment of upper urinary tract stones.
- 1 April 2025
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 35 (4) , 271-276
Does the 5-Item Modified Frailty Index Predict Adverse Outcomes after Retrograde Intrarenal Surgery? A Case—Control Study by the RIRSearch Group
Objectives: We aim to assess whether severely frail patients have an increased risk of complications and worse surgical outcomes after retrograde intrarenal surgery. Methods: The data of 340 consecutive patients undergoing retrograde intrarenal surgery to treat upper tract urinary stones were analyzed retrospectively. The 5-item modified frailty index (mFI-5) was used to assess the frailty status. Using a cutoff value of score 2 in the mFI-5 score, patients were divided into two groups: patients with an mFI-5 score Results: After matching confounding factors, Group 1 comprised 255 patients, and Group 2 comprised 85 patients. The baseline characteristics were similar between the groups. There were no statistically significant differences in terms of the median operation time and length of hospital stay among groups. There were no significant differences between groups for intraoperative complication rates (7.6% and 9.4%, respectively; P = .47) and postoperative complication rates (13.8% and 11.8%, respectively; P = .71), and stone-free rates (70.9% versus 72.9%, respectively; P = .73). Conclusions: Retrograde intrarenal surgery is an efficient and feasible treatment option for upper urinary tract stones in severely frail patients.
- 1 April 2025
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 35 (4) , 271-276
Does the 5-Item Modified Frailty Index Predict Adverse Outcomes after Retrograde Intrarenal Surgery? A Case—Control Study by the RIRSearch Group
Objectives: We aim to assess whether severely frail patients have an increased risk of complications and worse surgical outcomes after retrograde intrarenal surgery. Methods: The data of 340 consecutive patients undergoing retrograde intrarenal surgery to treat upper tract urinary stones were analyzed retrospectively. The 5-item modified frailty index (mFI-5) was used to assess the frailty status. Using a cutoff value of score 2 in the mFI-5 score, patients were divided into two groups: patients with an mFI-5 score Results: After matching confounding factors, Group 1 comprised 255 patients, and Group 2 comprised 85 patients. The baseline characteristics were similar between the groups. There were no statistically significant differences in terms of the median operation time and length of hospital stay among groups. There were no significant differences between groups for intraoperative complication rates (7.6% and 9.4%, respectively; P = .47) and postoperative complication rates (13.8% and 11.8%, respectively; P = .71), and stone-free rates (70.9% versus 72.9%, respectively; P = .73). Conclusions: Retrograde intrarenal surgery is an efficient and feasible treatment option for upper urinary tract stones in severely frail patients.
- Open Access
- 31 January 2025
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 29 (6) , 858-865
Risk factors for surgery in children with ureteropelvic junction obstruction due to antenatally detected ınfantil hydronephrosis
Background: Although the majority of cases with antenatally detected hydronephrosis (ANH) resolve during postnatal period; patients should be monitored for the risk of developing ureteropelvic junction obstruction (UPJO) which requires surgical intervention. We aimed to define independent risk factors for operation in whom diagnosis of UPJO was precisely proven with histopathological evidence. Methods: Medical files of 155 children (186 renal units) with anteroposterior pelvic diameter (APPD) ≥ 7 mm or ≥ 1SFU (Society of Fetal Urology) grade of pelvicalyceal dilatation were retrospectively investigated. Patients who underwent pyeloplasty and whose pathological examinations of resected ureteral samples confirmed obstruction, were compared to non-interventional group in terms of demographics, serum creatinine, APPD, SFU grade, cortical thickness and diuretic renogram. Multiple regression models were used to predict independent risk factors for pyeloplasty. Results: 155 patients (186 renal units) were recruited for the study. Pyeloplasty was performed in 50(32.2%) patients. Increased APPD, T1/2 and Tmax values with low parenchymal thickness and DRF were demonstrated in operated patients compared to those who did not. Significant decrease in APPD and T1/2 values and also significant improvement in parenchymal thickness were observed in conservatively managed group. Multivariate analysis revealed high APPD measurements and time activity curve patterns to be associated with significantly increased likelihood of surgical intervention. Conclusions: There is still an ongoing debate on which screening method should be used for the accurate diagnosis of UPJO or the indications for surgical intervention. Baseline APPD and diuretic renogram curve were found to be significant in predicting surgery for UPJO.
- 31 January 2025
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 29 (6) , 858-865
Open AccessRisk factors for surgery in children with ureteropelvic junction obstruction due to antenatally detected ınfantil hydronephrosis
Background: Although the majority of cases with antenatally detected hydronephrosis (ANH) resolve during postnatal period; patients should be monitored for the risk of developing ureteropelvic junction obstruction (UPJO) which requires surgical intervention. We aimed to define independent risk factors for operation in whom diagnosis of UPJO was precisely proven with histopathological evidence. Methods: Medical files of 155 children (186 renal units) with anteroposterior pelvic diameter (APPD) ≥ 7 mm or ≥ 1SFU (Society of Fetal Urology) grade of pelvicalyceal dilatation were retrospectively investigated. Patients who underwent pyeloplasty and whose pathological examinations of resected ureteral samples confirmed obstruction, were compared to non-interventional group in terms of demographics, serum creatinine, APPD, SFU grade, cortical thickness and diuretic renogram. Multiple regression models were used to predict independent risk factors for pyeloplasty. Results: 155 patients (186 renal units) were recruited for the study. Pyeloplasty was performed in 50(32.2%) patients. Increased APPD, T1/2 and Tmax values with low parenchymal thickness and DRF were demonstrated in operated patients compared to those who did not. Significant decrease in APPD and T1/2 values and also significant improvement in parenchymal thickness were observed in conservatively managed group. Multivariate analysis revealed high APPD measurements and time activity curve patterns to be associated with significantly increased likelihood of surgical intervention. Conclusions: There is still an ongoing debate on which screening method should be used for the accurate diagnosis of UPJO or the indications for surgical intervention. Baseline APPD and diuretic renogram curve were found to be significant in predicting surgery for UPJO.